Cargando…
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis
Background: Patients with rheumatic diseases (RDs) like DM are known to be vulnerable towards various types of infections due to aggressive disease activity mandating high dose immunosuppressive therapy. The severity of COVID-19 in RDs is limited in literature due to the heterogeneous nature of the...
Autores principales: | Pakhchanian, Haig, Khan, Hiba, Raiker, Rahul, Ahmed, Sakir, Kavadichanda, Chengappa, Abbasi, Maryam, Kardeş, Sinan, Agarwal, Vikas, Aggarwal, Rohit, Gupta, Latika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142211/ https://www.ncbi.nlm.nih.gov/pubmed/35750526 http://dx.doi.org/10.1016/j.semarthrit.2022.152034 |
Ejemplares similares
-
Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network
por: Raiker, Rahul, et al.
Publicado: (2021) -
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network
por: Raiker, Rahul, et al.
Publicado: (2021) -
Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States
por: Raiker, Rahul, et al.
Publicado: (2021) -
COVID-19 vaccination outcomes among patients with dermatomyositis: a multicentered analysis
por: Pakhchanian, Haig, et al.
Publicado: (2022) -
Reply to “Letter to the Editor Regarding ‘COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis’”
por: Pakhchanian, H, et al.
Publicado: (2023)